[Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study]

Cir Cir. 2016 Nov-Dec;84(6):459-468. doi: 10.1016/j.circir.2016.03.007. Epub 2016 May 21.
[Article in Spanish]

Abstract

Background: Sialorrhoea has a prevalence of between 10% and 58% in patients with cerebral palsy. Amongst the invasive treatments, botulinum toxin-A injections in submandibular and parotid glands and various surgical techniques are worth mentioning. There are no studies in Mexico on the usefulness of surgery to manage sialorrhoea.

Objective: To evaluate the usefulness of submandibular gland resection in improving sialorrhoea in patients with cerebral palsy and with a poor response to botulinum toxin.

Material and methods: Experimental, clinical, self-controlled, prospective trial was conducted to evaluate the grade of sialorrhoea before surgery, and 8, 16 and 24 weeks after. Statistical analysis was performed using a non-parametric repetitive measure assessment, considering a p < 0.05 as significant. Complications and changes in salivary composition were evaluated.

Results: Surgery was performed on 3 patients with severe sialorrhoea, and 2 with profuse sialorrhoea, with mean age of 10.8 years. The frequency and severity of sialorrhoea improved in the 5 patients, with mean of 76.7 and 87.5% improvement, respectively. The best results were seen after 6 months of surgery, with a statistically significant difference between the preoperative stage and 6 months after the procedure (p = 0.0039, 95% CI). No significant differences were observed in complications, increase in periodontal disease or cavities, or salivary composition.

Conclusions: Submandibular gland resection is an effective technique for sialorrhoea control in paediatric patients with cerebral palsy, with a reduction in salivary flow greater than 80%. It has a low chance of producing complications compared to other techniques. It led to an obvious decrease in sialorrhoea without the need to involve other salivary glands in the procedure.

Keywords: Botulinum toxin; Cerebral palsy; Glándulas salivales; Parálisis cerebral; Salivary glands; Sialorrea; Sialorrhoea; Toxina botulínica.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Botulinum Toxins, Type A / pharmacology
  • Botulinum Toxins, Type A / therapeutic use*
  • Cerebral Palsy / complications
  • Child
  • Drug Resistance
  • Humans
  • Pilot Projects
  • Prospective Studies
  • Severity of Illness Index
  • Sialorrhea / drug therapy
  • Sialorrhea / etiology
  • Sialorrhea / surgery*
  • Submandibular Gland / surgery*
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A